Maria Rotaru

Prof. Dr. Maria Rotaru


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016
Verified
Journal Article
Closed access
MDMichael David
Michael David
DGDimitar Konstantinov Gospodinov
Dimitar Konstantinov Gospodinov
NGNicola Gheorghe
Nicola Gheorghe
GMGrisha Stefanov Mateev
Grisha Stefanov Mateev
MRMariyana Venelinova Rusinova
Mariyana Venelinova Rusinova
PFPnina Fishman
Pnina Fishman

1 January 2014
Verified
Journal Article
Closed access
MRMaria Rotaru
Maria Rotaru
GIGabriela Mariana Iancu
Gabriela Mariana Iancu
LGLaura Gheucă-Solovăstru
Laura Gheucă-Solovăstru
RGRomaniţa-Firuţa Glaja
Romaniţa-Firuţa Glaja
FGFlorin Grosu
Florin Grosu
ACAdrian Costache
Adrian Costache

1 January 2014
Verified
Journal Article
Closed access
SMSilviu Horia Morariu
Silviu Horia Morariu
MRMaria Rotaru
Maria Rotaru
MVMihai Dorin Vartolomei
Mihai Dorin Vartolomei
MTMihai Turcu
Mihai Turcu
ACAndreea Luciana Chiotoroiu
Andreea Luciana Chiotoroiu
OCOvidiu Simion Cotoi
Ovidiu Simion Cotoi

1 January 2015
Verified
Journal Article
Closed access
MRMaria Rotaru
Maria Rotaru
ANAngelica-Elena Nati
Angelica-Elena Nati
IAIoan Avrămoiu
Ioan Avrămoiu
FGFlorin Grosu
Florin Grosu
GMGheorghe Dan Mălăescu
Gheorghe Dan Mălăescu

1 January 2014 in Revista Romana de Medicina de Laborator
Verified
Journal Article
Open access
MRMaria Rotaru
Maria Rotaru
GIGabriela Iancu
Gabriela Iancu
MMManuela Mihalache
Manuela Mihalache
GAGabriela Anton
Gabriela Anton
SMSilviu Morariu
Silviu Morariu
Background. Medical research has shown a continuous increase in the incidence of skin cancers, especially among young individuals. One of the ethiopathogenic factors that cause skin carcinogenesis could be the infection with some genotypes of human papillomavirus (HPV). Methods. In our study, we have analyzed alpha (α) - HPV positivity and HPV genotypes identified in melanocytic (MSC) and nonmelanocytic skin cancers (NMSC). The results were then compared with results obtained from the control group. The study included 40 cases of MSC and NMSC found in the data base of our hospital, and 40 healthy patients. In all of the cases, we identified the HPV DNA by using polymerase chain reaction (PCR), and the viral genotypes by using α -HPV primers by Linear Array Roche kit. Results. The average α-HPV positivity in tumors was 32.50%, higher than in other studies published to date. The squamous cell carcinoma (SCC) lot had the highest α-HPV positivity (40%), followed by basal cell carcinoma (BCC) (35%) and malignant melanoma (MM) (20%). The comparative analysis between skin cancer-HPV positive (32.50%) and the control group-HPV positive (15%) revealed a positivity of HPV in the tumors group (32.50%) that was higher by a ratio of 2.16. By viral genotyping, we identified high-risk HPV only in BCC and MM (in all α-HPV samples), but not in SCC samples. Conclusions. In our study, α-HPV in NMSC and MSC was positive in 32.50% of the cases; in 46.15% of these, it was possible to identify HPV genotypes. The high-risk HPV genotypes observed in these patients were HPV 16, 35, 58 and 59.

14 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LSLoredana Elena Stoica
Loredana Elena Stoica
MCMircea Sorin Ciolofan
Mircea Sorin Ciolofan
MMMihaela Roxana Mitroi
Mihaela Roxana Mitroi
MRMaria Rotaru
Maria Rotaru
GMGeorge G. Mitroi
George G. Mitroi
Sweet syndrome (SS) is a rare neutrophilic dermatosis often associated with hematologic malignancies, particularly myelodysplastic syndromes (MDSs). We report a case of SS-like dermatosis in a patient with MDS who subsequently developed peripheral T-cell non-Hodgkin lymphoma (NHL). We review the literature on Sweet syndrome to contextualize this atypical presentation Methods: We present a case report of a 77-year-old male with leukopenia and known MDS, admitted for a persistent, infiltrated erythematous eruption. The patient underwent repeated dermatologic assessments, and serial skin and bone marrow biopsies with histopathologic and immunohistochemical analysis. A literature review was also conducted, focusing on SS in association with hematologic malignancies, including T-cell NHL. Results: Initial skin biopsies were inconclusive, and SS was diagnosed clinically based on lesion morphology and a prompt response to corticosteroids, despite the absence of definitive neutrophilic infiltrates. During follow-up, the patient’s condition progressed with worsening cytopenias and recurrent febrile episodes. Repeat biopsies eventually confirmed the diagnosis of peripheral T-cell NHL with secondary hemophagocytic lymphohistiocytosis (HLH). Conclusions: This case illustrates the diagnostic uncertainty of SS-like eruptions in hematologic patients when histopathological findings are atypical or absent. Corticosteroid responsiveness may guide early diagnosis.